Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

Launched in 2017, Fortis is one of a handful of public recovery high schools in the country. Every semester, it enrolls ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets TRBC2-positive T-cell cancers, expanding a precision approach they established ...

President Donald Trump’s move to reclassify marijuana as a less dangerous drug departs from the tenets of the Wyoming MAGA ...

Abstract: Existing contingency screening (CS) methods focus on the transient dynamics of synchronous generators (SGs) but overlook the transient behaviors of power electronic converters, leaving a ...

In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...

Abstract: The paper presents an Automated Resume Screening System that leverages machine learning and natural language processing (NLP) to enhance the efficiency and objectivity of the recruitment ...

Valink Therapeutics ("Valink"), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities, and ...

Nona Biosciences is a global biotechnology company committed to cutting-edge technology innovations and providing integrated solutions from I to I (R) (Idea to IND), ranging from target validation and ...

– Monthly resettlement webinars to help prepare to leave the service – Monthly promotion support webinars designed to help officers navigate the four-step – National Police Promotion Framework (NPPF) ...

Doctors and researchers try to understand what medications a person has taken by asking patients directly or by looking at medical records. But this information is often incomplete. People may forget ...

Lilly’s closely watched retatrutide spurred as much as 29% weight loss in a Phase 3 study, a finding that is “raising the bar” for future obesity drug competitors, one analyst wrote. With the latest ...